HOXB13 is a susceptibility gene for prostate cancer: Results from the International Consortium for Prostate Cancer Genetics (ICPCG)

Human Genetics

Volumn 132, Issue 1, 2013, Pages 5-14

  Xu, Jianfeng ^a   Lange, Ethan M ^b,c   Lu, Lingyi ^a   Zheng, Siqun L ^a   Wang, Zhong ^a   Thibodeau, Stephen N ^d   Cannon Albright, Lisa A ^e   Teerlink, Craig C ^e   Camp, Nicola J ^e   Johnson, Anna M ^b   Zuhlke, Kimberly A ^b   Stanford, Janet L ^f   Ostrander, Elaine A ^f,g   Wiley, Kathleen E ^h,i   Isaacs, Sarah D ^h,i   Walsh, Patrick C ^h,i   Maier, Christiane ^j   Luedeke, Manuel ^j   Vogel, Walther ^j   Schleutker, Johanna ^k,l   Wahlfors, Tiina ^k   Tammela, Teuvo ^k,m   Schaid, Daniel ^d   McDonnell, Shannon K ^d   Derycke, Melissa S ^d   Cancel Tassin, Geraldine ^n,p   Cussenot, Olivier ^n,o   Wiklund, Fredrik ^q   Grönberg, Henrik ^q   Eeles, Ros ^r,s   Easton, Doug ^r,t   Kote Jarai, Zsofia ^r,s   Whittemore, Alice S ^u,v   Hsieh, Chih Lin ^u,w   Giles, Graham G ^r,x,y   Hopper, John L ^r,x,y   Severi, Gianluca ^r,x,y   Catalona, William J ^z,aa   Mandal, Diptasri ^ab,ac   Ledet, Elisa ^ab,ac   Foulkes, William D ^r,ad,ae   Hamel, Nancy ^r,ad,ae   Mahle, Lovise ^r,af   Moller, Pal ^r,af   Powell, Isaac ^ag,ah   Bailey Wilson, Joan E ^g,ag   Carpten, John D ^ag,ai   Seminara, Daniela ^aj   Cooney, Kathleen A ^b   Isaacs, William B ^h,i   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c IL   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j UNIVERSITY OF ULM   (Germany)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^l UNIVERSITY OF TURKU   (Finland)

^m TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁿ CeRePP ICPCG Group   (France)

^o HÔPITAL TENON   (France)

^p SORBONNE UNIVERSITÉ   (France)

^q KAROLINSKA INSTITUTE   (Sweden)

^r ACTANE   (United Kingdom)

^s INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^t UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^u STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v STANFORD CANCER INSTITUTE   (United States)

^w UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^x CANCER EPIDEMIOLOGY CENTRE   (Australia)

^y UNIVERSITY OF MELBOURNE   (Australia)

^z NORTHWESTERN UNIVERSITY   (United States)

^aa NORTHWESTERN UNIVERSITY   (United States)

^ab LOUISIANA STATE UNIVERSITY   (United States)

^ac LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ad MCGILL UNIVERSITY   (Canada)

^ae RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^af OSLO UNIVERSITY HOSPITAL   (Norway)

^ag ICPCG Group   (United States)

^ah WAYNE STATE UNIVERSITY   (United States)

^ai TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^aj NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOXB13 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HOMEODOMAIN PROTEINS; HUMANS; INTERNATIONAL AGENCIES; MALE; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84872308743     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1229-4     Document Type: Article

References (32)

1. Agalliu I, Karlins E, Kwon EM et al (2007) Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. Br J Cancer 97:826-831
2. Akamatsu S, Takata R, Haiman CA et al (2012) Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet 44(426-9):S1
3. Bodmer W, Bonilla C (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40(6):695-701
4. Carpten J, Nupponen N, Isaacs S et al (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30:181-184
5. Cropp CD, Simpson CL, Wahlfors T, Ha N, George A, Jones MS, Harper U, Ponciano-Jackson D, Green TA, Tammela TL, Bailey-Wilson J, Schleutker J (2011) Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22. Int J Cancer 129:2400-2407
6. Edwards SM, Kote-Jarai Z, Meitz J et al (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72:1-12
7. Eeles RA, Kote-Jarai Z, Giles GG et al (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40:316-321
8. Eeles RA, Kote-Jarai Z, Al Olama AA et al (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41:1116-1121
9. Ewing CM, Ray AM, Lange EM et al (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366:141-149
10. Gillanders EM, Xu J, Chang BL et al (2004) Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst 96:1240-1247
11. Gudmundsson J, Sulem P, Manolescu A et al (2007a) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637
12. Gudmundsson J, Sulem P, Steinthorsdottir V et al (2007b) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39:977-983
13. Gudmundsson J, Sulem P, Rafnar T et al (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40:281-283
14. Gudmundsson J, Sulem P, Gudbjartsson DF et al (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41:1122-1126
15. Haiman CA, Chen GK, Blot WJ et al (2011) Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 43:570-573
16. Iyengar SK, Elston RC (2007) The genetic basis of complex traits: rare variants or "common gene, common disease". Methods Mol Biol 376:71-84
17. Kote-Jarai Z, Olama AA, Giles GG et al (2011a) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 43:785-791
18. Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, Mahmud N, Guy M, Edwards S, O'Brien L, Sawyer E, Hall A, Wilkinson R, Dadaev T, Goh C, Easton D, UKGPCS Collaborators, Goldgar D, Eeles R (2011b) BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer 105(8):1230-1234. doi: 10.1038/bjc.2011.383
19. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
20. Lange EM, Gillanders EM, Davis CC et al (2003) Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 57:326-334
21. Lange EM, Robbins CM, Gillanders EM et al (2007) Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum Genet 121:49-55
22. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
23. Schaid DJ, Chang BL (2005) Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 63:276-290
24. Sun J, Zheng SL, Wiklund F et al (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 40:1153-1155
25. Takata R, Akamatsu S, Kubo M et al (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 42:751-754
26. Tavtigian SV, Simard J, Teng DH et al (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27:172-180
27. Thomas G, Jacobs KB, Yeager M et al (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310-315
28. Xu J, Zheng SL, Komiya A et al (2002) Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 32:321-325
29. Xu J, Dimitrov L, Chang BL et al (2005) A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 77:219-229
30. Xu J, Zheng SL, Isaacs SD et al (2010) Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci USA 107:2136-2140
31. Yeager M, Orr N, Hayes RB et al (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649
32. Yeager M, Chatterjee N, Ciampa J et al (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41:1055-1057